How has the doctrine of maximizing short-term shareholder profits—part of the growing influence of financial actors and strategies termed financialization—come at the expense of patients and public health in the U.S.?
Join us on February 24 for a discussion of new research on the trillions of dollars extracted from the healthcare system through financial engineering practices like stock buybacks, how this falls into a broader pattern of publicly traded companies prioritizing short-term shareholder payouts above all else, and the impact of these practices on workers, patients, and innovation.
Don’t miss the chance to hear from experts in health policy and political economy about how healthcare corporations are increasingly serving Wall Street, with devastating implications for our healthcare system and patients, and what we can do about it.
Speakers:
This event is co-sponsored by Americans for Financial Reform Education Fund (AFREF) and the Health and Political Economy Project (HPEP) at The New School’s Institute on Race, Power and Political Economy.